Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 8, 2025
[Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple sclerosis)]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Comments on the GLIMPSE study on evaluating the efficacy of the drug cladribine in tablets in routine clinical practice in comparison with other tablet drugs for the pathogenetic treatment of multiple sclerosis]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 15, 2020
[An additional analysis of the efficacy and safety of therapy in the Russian population of patients with multiple sclerosis participated in phase III international multicenter clinical trials: results of alemtuzumab study]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 4, 2019
[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Tyrosine kinases: a target of epigenetic influences and a new direction in the treatment of multiple sclerosis]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 16, 2017
[Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient]
A N Boyko, E I Gusev
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 10, 2023
[The need to validate translations into Russian of objective neurological scales, symptoms and syndromes]
A N Boyko, M N Zakharova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 24, 2018
[An analysis of clinical trials on the registration of similars of the original disease-modifying therapies]
A N Boyko, M N Zakharova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
December 22, 2017
[Efficacy, safety and tolerability of glatiramer acetate injections in dose 40 mg/ml in patients with relapsing-remitting multiple sclerosis]
A N Boyko, V M Alifirova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[The possibility of using multiple sclerosis-associated variants of the mitochondrial genome to predict the development of multiple sclerosis]
M A Omarova, A N Boyko
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 8, 2025
[Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple sclerosis)]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Comments on the GLIMPSE study on evaluating the efficacy of the drug cladribine in tablets in routine clinical practice in comparison with other tablet drugs for the pathogenetic treatment of multiple sclerosis]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 15, 2020
[An additional analysis of the efficacy and safety of therapy in the Russian population of patients with multiple sclerosis participated in phase III international multicenter clinical trials: results of alemtuzumab study]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 4, 2019
[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Tyrosine kinases: a target of epigenetic influences and a new direction in the treatment of multiple sclerosis]
A N Boyko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 16, 2017
[Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient]
A N Boyko, E I Gusev
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 10, 2023
[The need to validate translations into Russian of objective neurological scales, symptoms and syndromes]
A N Boyko, M N Zakharova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 24, 2018
[An analysis of clinical trials on the registration of similars of the original disease-modifying therapies]
A N Boyko, M N Zakharova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
December 22, 2017
[Efficacy, safety and tolerability of glatiramer acetate injections in dose 40 mg/ml in patients with relapsing-remitting multiple sclerosis]
A N Boyko, V M Alifirova
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[The possibility of using multiple sclerosis-associated variants of the mitochondrial genome to predict the development of multiple sclerosis]
M A Omarova, A N Boyko
Page
of 14